COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 165 filers reported holding COHERUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $115 | -40.1% | 28,080 | 0.0% | 0.01% | -43.8% |
| Q1 2023 | $192 | -13.5% | 28,080 | 0.0% | 0.02% | -15.8% |
| Q4 2022 | $222 | -99.9% | 28,080 | 0.0% | 0.02% | -24.0% |
| Q3 2022 | $270,000 | +33.0% | 28,080 | 0.0% | 0.02% | +38.9% |
| Q2 2022 | $203,000 | +34.4% | 28,080 | +140.2% | 0.02% | +50.0% |
| Q1 2022 | $151,000 | -19.3% | 11,690 | 0.0% | 0.01% | -14.3% |
| Q4 2021 | $187,000 | -0.5% | 11,690 | 0.0% | 0.01% | -6.7% |
| Q3 2021 | $188,000 | +16.0% | 11,690 | 0.0% | 0.02% | +15.4% |
| Q2 2021 | $162,000 | -5.3% | 11,690 | 0.0% | 0.01% | -18.8% |
| Q1 2021 | $171,000 | -15.8% | 11,690 | 0.0% | 0.02% | -20.0% |
| Q4 2020 | $203,000 | -5.1% | 11,690 | 0.0% | 0.02% | -16.7% |
| Q3 2020 | $214,000 | – | 11,690 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |